	recommendation reiterated on wang labs wanb analyst thomas mccrann of merrill lynch said he reiterated a buy recommendation of wang laboratories inc noting that a successful cost cutting campaign could reduce the ings loss expected for the third quarter ending in march wang was the most actively traded stock on the american stock exchange rising to mccrann said that wang is a little bit ahead of where they were expected to be in their cost reductions and as a result the odds have increased that the loss for the quarter will be less than had been expected mccrann said he expects wang to report break even ings per share or only a small loss per share for the third quarter he said for the year however the company should report a loss of about cts a share compared with ings of about cts a share a year ago reuter 
